| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |